Spironolactone Tablet, Coated
Product Images NDC 82804-285

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 82804-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival plot comparing Spironolactone and placebo groups over 48 months. The y-axis represents probability, and the x-axis represents time in months. The graph shows a higher survival probability for Spironolactone (n=822) compared to placebo (n=841), with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot chart displaying hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The x-axis ranges from 0.2 to 1.4, indicating relative effectiveness of Spironolactone versus placebo.*
FDA Label Image

82804-285-30 (Image 01)

82804-285-30 (Image 01)
Spironolactone 50 mg coated tablets blister label from Proficient Rx LP. The label includes a quantity of 30 tablets, storage instructions (20°-25°C), and detailed tablet description (oval, white to off-white, scored, convex, debossed with 853 and '0'). Manufacturer listed as Oxford Pharmaceuticals, LLC, Birmingham, Alabama. Includes NDC 82804-285-30 and barcodes.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone showing its molecular components and bonds as a steroidal framework with characteristic lactone and thioacetate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.